FibroBiologics (FBLG) Payables (2022 - 2026)
FibroBiologics (FBLG) posted quarterly Payables of $1.8 million for Q2 2026, down 81.54% year-over-year from $9.9 million in Q2 2025, and up 114.24% on a QoQ basis from $850000.0 in Q1 2026.
FibroBiologics (FBLG) Payables (2022 - 2026) Analysis & Trends
FibroBiologics has reported Payables for 5 years, with the latest figure at $1.8 million in Q2 2026.
- Payables for Q2 2026 came in at $1.8 million, down 81.54% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.8 million (down 81.54% YoY), and the FY2025 annual result was $12.5 million, down 1.2% from the prior year.
- Payables advanced to $1.8 million in Q2 2026, from $850000.0 in the prior quarter.
- Over five years, Payables peaked at $12.7 million in Q4 2024 and troughed at $850000.0 in Q1 2026.
- A 5-year average of $5.6 million and a median of $4.0 million in 2022 frame the typical range for Payables.
- The widest annual swing landed in 2024, when Payables jumped 779.29%; it then slumped 88.29% in 2026.
- A 5-year view of Payables shows it stood at $6.2 million in 2022, then plunged by 76.74% to $1.4 million in 2023, then jumped by 779.29% to $12.7 million in 2024, then slipped by 1.2% to $12.5 million in 2025, then slumped by 85.48% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $1.8 million in Q2 2026, $850000.0 in Q1 2026, and $12.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | FibroBiologics | 8.15 Mn | 8.15 Mn | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Mn |
| Mar 31, 2026 | 850,000.00 |
| Dec 31, 2025 | 945,000.00 |
| Sep 30, 2025 | 10.77 Mn |
| Jun 30, 2025 | 9.87 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 12.70 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 1.30 Mn |